However, immunohistochemical study showed a conspicuously significant decrease of human proliferation marker Ki67 in the DMH1 treated versus vehicle groups, suggesting that DMH1 treatment may attenuate human A549 cancer cell proliferation in vivo (Figure 4C). This evidence concerns the gene MKI67 and cancer.